Biovica International AB (publ) (STO:BIOVIC.B)

Revenue by Segment

Financials in millions SEK. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
Biotechnology	13.49M	8.65M	7.30M	5.21M	5.10M
Total	13.49M	8.65M	7.30M	5.21M	5.10M

Revenue by Geography

Financials in millions SEK. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
EU Excl. Sweden	1.19M	531.00K	1.37M	125.00K	102.00K
USA	11.69M	7.55M	5.58M	3.26M	1.94M
Asia	507.00K	536.00K	-	-	-
Sweden	-	-	41.00K	-	-
Rest of The World	-	-	297.00K	-	-
Total	13.38M	8.62M	7.29M	3.38M	2.05M

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error